BioImpact Capital

MPM BioImpact is a Boston-based venture capital firm investing across biotechnology and life sciences, with emphasis on early-stage company building, therapeutics, oncology and pharmaceutical drug development. The firm invests in the United States and Asia-Pacific, with activity spanning seed, Series A and Series B financings, and has acted as a lead or co-lead investor. It manages over $3 billion across early-stage venture, private/public impact and public equities funds; portfolio company-building examples include BioMarin Pharmaceuticals, Pharmasset, Cullinan Therapeutics and Orna Therapeutics.